BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2001

View Archived Issues

Amsterdam biotechnology company licenses DKFZ's AAV vector technology

Read More

Human antibody alliance expanded by Abgenix and Chiron

Read More

InterMune updates development status of Actimmune

Read More

Dose-dependent response reported by La Jolla for LJP-394 at recent lupus conference

Read More

Aradigm receives milestone payment for development of AERx Diabetes Management System

Read More

Epimmune and Elan establish licensing agreement for PADRE technology

Read More

Development of therapeutics targeting CXCR4 accelerated at Northwest Biotherapeutics

Read More

Health Canada approves Allergan's Botox for treatment of glabellar lines

Read More

Synaptic on track to file IND for lead antidepressant drug candidate

Read More

Met-enkephalin shows potential as an AIDS therapeutic vaccine

Read More

Secretin reported to produce significant clinical response in autism

Read More

First phase III results for IC-351 discussed by Lilly Icos at EAU meeting

Read More

AstraZeneca beta-blocker now available in U.S. for heart failure treatment

Read More

Alzheimer's disease development candidate related to donepezil identified at Eisai

Read More

Potent, orally active anorectic agents identified in DuPont 5-HT2C ligand program

Read More

RWJ-58259 characterized simultaneously at ACS and in major scientific journal

Read More

Zometa approved in E.U. for TIH treatment

Read More

University of Pittsburgh researchers begin study of rofecoxib for prevention of colon polyps

Read More

U.S. university investigators identify antitrypanosomal dicationic reversed amidines

Read More

Nymox study confirms link between spherons and senile plaques

Read More

Targeted anticancer agent featured in New England Journal of Medicine

Read More

Use of modafinil in anorexia

Read More

Combination therapies for restless legs syndrome devised by Boehringer Ingelheim

Read More

Schering-Plough patents use of antiallergic agents for CNS, vascular disorders

Read More

GABA-A receptor ligands from MS&D particularly useful in anxiety Rx

Read More

Antibacterial 9a-azalide series described in recent patent by Abbott

Read More

NPY antagonists with selectivity for Y5 receptors and their use in eating disorders

Read More

Series of potent and selective tryptase inhibitors discovered at Morphochem

Read More

ConjuChem progresses clinical studies of two products during fiscal Q1 2001

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing